FDA Accepts Alkermes ' Resubmission of New Drug Application for ALKS 3831

DUBLIN, Dec. 29, 2020 /PRNewswire/ -- Alkermes plc (Nasdaq: ALKS) today announced that the U.S. Food and Drug Administration (FDA) has acknowledged receipt of the company ' s New Drug Application (NDA) resubmission for...
Source: Drugs.com - New Drug Applications - Category: Drugs & Pharmacology Source Type: news